Research institute launches tender for broad sequencing services
A research body is seeking suppliers for metagenomic, transcriptomic, amplicon, Sanger and whole genome sequencing under strict quality conditions.
A research body is seeking suppliers for metagenomic, transcriptomic, amplicon, Sanger and whole genome sequencing under strict quality conditions.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.
Published on 3rd March 2026, Natural Resources Institute Finland (Luonnonvarakeskus) has gone to market for a comprehensive package of DNA and RNA sequencing services. The Sequencing Services Procurement contract notice covers metagenomic, transcriptomic, amplicon, Sanger and whole genome sequencing, and sets specific expectations on quality and turnaround times.
Natural Resources Institute Finland is seeking suppliers for a range of sequencing services that together span both established and next-generation methods. The notice specifies that providers must meet defined quality thresholds and turnaround times, signalling that the institute expects sequencing to support routine, time-sensitive workflows.
The service mix brings several techniques under one procurement:
Bundling these services tends to favour bidders able to operate across multiple platforms and chemistries, rather than niche providers focused on a single technique.
The sequencing tender follows closely on another data-focused procurement from the same buyer. In February 2026, Luonnonvarakeskus published a notice for Statistical Data Collection Services, seeking offers for structured data gathering.
Taken together, these procurements show the institute investing along a broad data chain, from statistical data collection through to high-resolution molecular information. For sequencing suppliers, that points to outputs that must integrate with other datasets and analytical processes.
The Finnish notice aligns with a clear pattern of research and clinical organisations sourcing sequencing as an external service rather than only investing in their own instruments. On 2nd March 2026, Tartu Ülikool issued a contract notice for Whole Genome Sequencing Services for microorganisms, specifying technical requirements in a dedicated description.
In January 2026, Université catholique de Louvain launched a framework for High-Throughput Sequencing Services, combining short-fragment work on Illumina platforms with very long reads on PacBio and including methylation profiling. Universitätsklinikum Maribor followed a similar path in January 2026 with its Next Generation Sequencing services notice.
The outsourcing model is also evident in university and clinical research settings. In November 2025, Rīgas Stradiņa universitāte sought NGS Outsourcing Services covering prepared libraries, library preparation and several specialised applications. In December 2025, Fundación Instituto de Investigación Sanitaria Illes Balears went to market for Genomic Sequencing Services to support biomedical projects in the Balearic Islands.
Clinical buyers are using similar routes for highly specialised analysis. A notice from Spitalul Clinic de Urgenta pentru Copii Louis Turcanu in January 2026 seeks DNA Sequencing Services for whole exome and mitochondrial genomes, while Meditsinski universitet - Plovdiv issued a Sequencing Services Procurement in December 2025 for complete exome and targeted tumour DNA sequencing. In December 2025, Universitatea de Medicina si Farmacie \"Iuliu Hatieganu\" Cluj-Napoca went further, procuring Sequencing Libraries for Transcriptomic Analysis and primary data analysis for spatial transcriptomics in rare thyroid cancer.
Against this backdrop, Natural Resources Institute Finland’s decision to contract in sequencing capacity fits a broader shift: large organisations increasingly see high-end genomics as a service they can buy on demand, provided suppliers can meet strict performance and delivery standards.
Not all buyers are relying on outsourcing alone. Many are investing directly in sequencing platforms, often coupled with long-term reagent supply. In September 2025, Centre Hospitalier Universitaire de Nîmes published a notice for Long Read Sequencer Acquisition, bundling installation, maintenance, accessories and consumables. That same month, Meditsinski universitet sought delivery, installation and staff training for a nanopore-based long-read system in its Specialized Equipment Delivery tender.
Hospitals are also procuring integrated solutions that combine hardware, consumables and software. Universitätsklinikum Halle (Saale) AöR is seeking an Integrated Sequencer Solution with an automated workflow, leasing and purchase options, consumables and training. ASST SPEDALI CIVILI DI BRESCIA’s October 2025 notice for Supply of NGS Systems and Reagents similarly ties together analytical systems, sequencers, reagents and bioinformatics software for an extended period, while Unidade Local de Saúde de Santo António, E. P. E. is acquiring Equipment for Sequencing Services with both high- and medium-throughput capacity.
Elsewhere, buyers are pairing major platform investments with project-specific goals. In October 2025, Institutul Regional de Oncologie Iasi launched a Medical Equipment Procurement for a high-capacity NGS platform under the Onco-Perfmed project, while Universitatea de Medicina si Farmacie \"Carol Davila\" is procuring Genomic Research Equipment Supply for high-throughput and portable systems across medical research institutions. The Shotgun Sequencing System Procurement by Institutou Georgikon Ereunon in September 2025 adds a metagenomic angle, with equipment to assemble microbial metagenomes and supply operational materials.
Reagents and library preparation form a further layer of the market. In September 2025, Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi tendered for Supply of Diagnostic Kits and Reagents for DNA and RNA library preparation, while Pécsi Tudományegyetem’s Sequencing Reagent Kits Procurement targets NovaSeq X Series flow cells and consumables. Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinikos combines both aspects, acquiring Reagents and Tools for Tumor Sequencing together with a new-generation sequencing system on a loan basis.
As datasets grow, some buyers are procuring not only instruments and wet-lab services but also cloud-based analysis environments. In December 2025, Meditsinski universitet-Varna \"Prof. D-r Paraskev Iv.Stoyanov\" launched a tender for a Cloud Platform Subscription for Sequencing, covering a 12-month access package to manage sequencing processes, bioinformatics analysis, variant interpretation and reporting. The Brescia procurement for NGS systems explicitly includes bioinformatics software, and the Cluj-Napoca spatial transcriptomics tender builds analysis of primary data into its scope.
Natural Resources Institute Finland’s sequencing notice does not detail downstream pipelines, but its emphasis on specific quality and turnaround time requirements implies a need for well-organised logistics and data handling. Suppliers positioning for this contract will need to demonstrate not just laboratory capacity across metagenomic, transcriptomic, amplicon, Sanger and whole genome workflows, but also reliable processes for delivering high-quality data back to the institute on schedule.
The new sequencing services procurement from Luonnonvarakeskus is another signal that advanced genomics has become routine infrastructure for research and clinical work. It sits alongside equipment-heavy tenders, reagent supply contracts and cloud-platform subscriptions, showing how institutional buyers are mixing in-house capability with outsourced services.
For the sequencing market, the breadth of techniques covered in this notice is notable. Future procurements of this kind are likely to sharpen expectations on quality assurance, turnaround and integration with statistical and informatics workflows. How suppliers respond will help determine whether large research institutes continue to source sequencing as a flexible external service or move further towards owning their own multidimensional sequencing stacks.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.